Continuing to heal after cancer For more than 12 million U.S. cancer survivors, accepting a ‘new normal’ is easier said than done. Cancer survivor Dr. Julie Silver started a national rehabilitation program to help patients heal – even after treatments end
Web information on prostate cancer tough to understand There's no shortage of websites with information on prostate cancer treatment, but they may be well beyond the average person's comprehension
'Thirdhand' smoke poses cancer risk New research out of the Lawrence Berkeley National Laboratory has found that the residue from smoking indoors – so-called “thirdhand smoke” – has the potential to cause cancer.
Mom captures touching moment shared between two pediatric cancer patients A photo that captured a shared moment between two children undergoing chemotherapy to treat cancer at Children’s Hospital of Pittsburgh has gone viral, resulting in countless well wishes and messages of encouragement for the two girls featured in it.
Justina Pelletier back in hospital, family says Justina Pelletier, the teen who was at the center of a bitter custody battle triggered by differing diagnoses at two Massachusetts hospitals, is back in the hospital, a family member told FoxNews.com.
FDA approves Pfizer's high profile breast cancer drug The U.S. Food and Drug Administration on Tuesday approved Pfizer Inc's Ibrance, a potential new standard of care for advanced breast cancer, in a regulatory decision that came more than two months earlier than expected.
Thyroid cancer cases soar; is it overdiagnosed? A dramatic rise in thyroid cancer has resulted from overdiagnosis and treatment of tumors too small to ever cause harm, according to a study that found cases nearly tripled since 1975.
Abnormal vaginal bleeding rare but serious cancer sign For women with regular periods, abnormally heavy bleeding may be a sign of blood cancer, and although this symptom is rare, it shouldn't be missed, a new study says.
What a mammogram could do for you: Study lays out risk, benefits To maximize the benefits and lower the risks of routine mammograms for breast cancer screening, it's best to base decisions on each woman's individual risk level, as well as her values and priorities, researchers concluded after reviewing 50 years of studies on mammograms.
Bristol-Myers' Opdivo found effective in kidney cancer Bristol-Myers Squibb Co said a late-stage trial of its drug, Opdivo, was stopped early after the immunotherapy was found to be effective in patients with the most common form of kidney cancer.
